Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer [NA]
Clinical trial assessing the efficiency of offline adaptive radiotherapy for advanced non-small cell lung cancer is currently recruiting, sp…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy
This clinical trial update discusses survival analysis and prognostic biomarker exploration for postoperative adjuvant therapy patterns in n…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer [Phase 2]
This document notes that SHR-A2102 is being evaluated in a Phase 2 trial in combination with other anti-tumor therapies for resectable non-s…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab [Phase 2]
This clinical trial update describes a Phase 2 randomized study comparing standard-of-care treatment to an immune-based combination for rela…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Influence of Food Preferences on the Occurrence of Undernutrition in Treated Patients for Bronchopulmonary Carcinoma Non-small Cell Stage IV [NA]
A clinical trial update examining whether food preferences influence undernutrition in treated patients with stage IV non-small cell lung ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations
A prospective cohort study in locally advanced and metastatic non-small cell lung cancer patients with activating EGFR mutations is currentl…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Postoperative Pulmonary Function Assessment Based on Deep Learning Study [NA]
This clinical trial registry entry from The Chinese University of Hong Kong describes evaluating postoperative pulmonary function in non-sma…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: A Study to Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating the safety and efficacy of a WSD0922-FU combination with Osimertinib in non-small cell lung cancer;…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer. [NA]
A clinical trial investigating a process to optimize decisions about continuing or stopping cancer treatments in patients with advanced non-…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating whether adding durvalumab to radiation therapy can prevent progression of non-small cell lung cancer;…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. [Phase 1]
Phase 1 trial update of Naptumomab Estafenatox in combination with durvalumab in selected advanced or metastatic solid tumors, including eso…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer [Phase 2]
The document reports a Phase 2 clinical trial update for Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in advanced or unresectable/metastatic …
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC [Phase 2]
A Phase 2 clinical trial is investigating an osimertinib-based adaptive treatment guided by ctDNA EGFR mutation monitoring in locally advanc…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial update examining how infusion timing affects pathologic response to neoadjuvant immunotherapy in resectable non-small…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC
This is a clinical trial update about adjuvant chemotherapy for high-risk pathologic stage I non-small cell lung cancer. The trial status is…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study of YL202 in Selected Patients With Advanced Solid Tumors [Phase 2]
Phase 2 study of YL202 in selected patients with advanced solid tumors including non-small cell lung cancer, breast cancer, and head and nec…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Positive Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01B/KEYMAKER-U01B) [Phase 2]
A Phase 2 trial evaluating pembrolizumab with investigational agents in treatment-naïve PD-L1-positive advanced non-small cell lung cancer h…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial of a carcinoembryonic antigen (CEA)-targeted CAR-T therapy in patients with CEA-positive advanced solid tumors, inc…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating platinum-based doublet chemotherapy with proton beam radiation for unresectable stage II–III non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial update evaluating the sequencing of pembrolizumab alone or with chemotherapy as first-line therapy and maintenance in non-smal…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers [Phase 1]
Phase 1 clinical trial evaluating hypofractionated radiotherapy in combination with durvalumab (MEDI4736) and tremelimumab in patients with …
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC [NA]
This document reports that a real-world, first-line trial of sugemalimab in combination with chemotherapy for advanced non-small cell lung c…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Clinical Trial of TB511 in Advanced Solid Tumors [Phase 1, Phase 2]
This update covers an early-phase trial of TB511 in advanced solid tumors, including non-small cell lung cancer and prostate cancer, with co…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)
Clinical trial update describing a study on long-term responders in metastatic lung cancer to improve management, currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial update testing Telaglenastat and Sapanisertib in advanced non-small cell lung cancer with brain and leptomeningeal me…